Apply for 72049218APS00001
- The Agency for International Development, Philippines USAID-Manila in the health sector is offering a public funding opportunity titled "Improved Health for Underserved Filipinos" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on May 11, 2018.
- Applicants must submit their applications by May 11, 2019.
- Each selected applicant is eligible to receive up to $49,000,000.00 in funding.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Browse more opportunities from the same category: Health
Next opportunity: Park Planner to Support Deferred Maintenance Projects at Joshua Tree National Park
Previous opportunity: Food Diplomacy: A Recipe for Entrepreneurship
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for 72049218APS00001
Applicants also applied for:
Applicants who have applied for this opportunity (72049218APS00001) also looked into and applied for these:
|Funding Number||Funding Title|
|SM 18 019||Certified Community Behavioral Health Clinic Expansion Grants|
|RFA NS 18 032||Research Program Award (R35 Clinical Trial Optional)|
|CDC RFA DP18 1813||Racial and Ethnic Approaches to Community Health (REACH)|
|RFA HL 19 018||NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)|
|RFA HL 19 017||NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)|
|RFA HL 19 010||Limited Competition: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required)|
|RFA HL 19 009||Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trial Not Allowed )|
|HQ0034 18 1 0002||ARC Congressional Grant|
|72049218APS00001 02||ARMM Health Capacity Building Activity|
|RFI 625 18 RISEII HSD||RISE II HEALTH SERVICES DELIVERY ACTIVITY|
|HRSA 18 121||Vulnerable Rural Hospitals Assistance Program|
|CDC RFA DP18 1815||Diabetes and Heart Disease & Stroke Prevent Programs-Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke|
|72067418RFA00008||Community-Based Violence Prevention and Linkages to Response in South Africa|
|72066318RFA00001||Health Financing Improvement Program|
|HRSA 18 115||Expansion of the Family-to-Family Health Information Centers|
|RFA RM 18 009||NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)|
|RFA RM 18 008||NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)|
|HRSA 18 112||Behavioral Health Workforce Education and Training (BHWET) Program – Supplemental Funding|
|TI 18 014||Provider’s Clinical Support System – Universities (Short Title: PCSS-Universities)|
|CDC RFA CE13 13060501SUPP18||National Technical Assistance Resource Center for the Prevention of Sexual Violence|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72049218APS00001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.